Chronic anemia resistant to erythropoietin in a patient treated with gemcitabine showing a hemolytic uremic syndrome (HUS).
C
C
Assi
C
C
Lepage
J-L
JL
Jouve
C
C
Sgro
L
L
Bedenne
D000368:Aged; D000740:Anemia / Q000188:drug therapy / Q000209:etiology*; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage / Q000009:adverse effects*; D002908:Chronic Disease; D003841:Deoxycytidine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D004921:Erythropoietin / Q000627:therapeutic use*; D006463:Hemolytic-Uremic Syndrome / Q000139:chemically induced* / Q000150:complications; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy / Q000556:secondary; D008297:Male; D010190:Pancreatic Neoplasms / Q000188:drug therapy / Q000556:secondary; D017211:Treatment Failure; D000093542:Gemcitabine
D000964:Antimetabolites, Antineoplastic; D003841:Deoxycytidine; D004921:Erythropoietin; D000093542:Gemcitabine